115 related articles for article (PubMed ID: 33993482)
1. Integrated transcriptomic and proteomic analysis of microplasts derived from macrophage-conditioned medium-treated MCF-7 breast cancer cells.
Melwani PK; Balla MMS; S N; Padwal M; Chaurasia RK; Basu B; Ghosh A; Pandey BN
FEBS Lett; 2021 Jul; 595(13):1844-1860. PubMed ID: 33993482
[TBL] [Abstract][Full Text] [Related]
2. Macrophage conditioned medium induced cellular network formation in MCF-7 cells through enhanced tunneling nanotube formation and tunneling nanotube mediated release of viable cytoplasmic fragments.
Patheja P; Sahu K
Exp Cell Res; 2017 Jun; 355(2):182-193. PubMed ID: 28412243
[TBL] [Abstract][Full Text] [Related]
3. Significant alterations of the novel 15 gene signature identified from macrophage-tumor interactions in breast cancer.
Singh R; Dagar P; Pal S; Basu B; Shankar BS
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):669-683. PubMed ID: 29248526
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism.
Gelsomino L; Barone I; Caruso A; Giordano F; Brindisi M; Morello G; Accattatis FM; Panza S; Cappello AR; Bonofiglio D; Andò S; Catalano S; Giordano C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361728
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of exosome-like vesicles from breast cancer cells.
Kruger S; Abd Elmageed ZY; Hawke DH; Wörner PM; Jansen DA; Abdel-Mageed AB; Alt EU; Izadpanah R
BMC Cancer; 2014 Jan; 14():44. PubMed ID: 24468161
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts.
Niada S; Giannasi C; Magagnotti C; Andolfo A; Brini AT
J Proteomics; 2021 Feb; 232():104069. PubMed ID: 33309826
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
Jordan KR; Hall JK; Schedin T; Borakove M; Xian JJ; Dzieciatkowska M; Lyons TR; Schedin P; Hansen KC; Borges VF
Breast Cancer Res; 2020 Nov; 22(1):128. PubMed ID: 33225939
[TBL] [Abstract][Full Text] [Related]
8. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
9. Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines.
Fiskaa T; Knutsen E; Nikolaisen MA; Jørgensen TE; Johansen SD; Perander M; Seternes OM
PLoS One; 2016; 11(8):e0161824. PubMed ID: 27579604
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
[TBL] [Abstract][Full Text] [Related]
11. Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi-omic analysis.
Lane RE; Korbie D; Khanna KK; Mohamed A; Hill MM; Trau M
Proteomics; 2024 Jun; 24(11):e2300089. PubMed ID: 38168906
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.
Zhou X; Li T; Chen Y; Zhang N; Wang P; Liang Y; Long M; Liu H; Mao J; Liu Q; Sun X; Chen H
Int J Oncol; 2019 May; 54(5):1843-1852. PubMed ID: 30864702
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
Whelan SA; He J; Lu M; Souda P; Saxton RE; Faull KF; Whitelegge JP; Chang HR
J Proteome Res; 2012 Oct; 11(10):5034-45. PubMed ID: 22934887
[TBL] [Abstract][Full Text] [Related]
14. Integrated Transcriptomics, Proteomics, and Glycomics Reveals the Association between Up-regulation of Sialylated N-glycans/Integrin and Breast Cancer Brain Metastasis.
Peng W; Zhu R; Zhou S; Mirzaei P; Mechref Y
Sci Rep; 2019 Nov; 9(1):17361. PubMed ID: 31758065
[TBL] [Abstract][Full Text] [Related]
15. Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion.
Lee JE; Moon PG; Cho YE; Kim YB; Kim IS; Park H; Baek MC
J Proteomics; 2016 Jan; 131():17-28. PubMed ID: 26463135
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of exosome-like vesicles derived from breast cancer cells.
Palazzolo G; Albanese NN; DI Cara G; Gygax D; Vittorelli ML; Pucci-Minafra I
Anticancer Res; 2012 Mar; 32(3):847-60. PubMed ID: 22399603
[TBL] [Abstract][Full Text] [Related]
18. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
19. Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7.
Alghanem B; Ali R; Nehdi A; Al Zahrani H; Altolayyan A; Shaibah H; Baz O; Alhallaj A; Moresco JJ; Diedrich JK; Yates JR; Boudjelal M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570693
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Proteomic-Transcriptomic Investigation of Monocarboxylate Transporter 6 Knockout Mice: Evidence of a Potential Role in Glucose and Lipid Metabolism.
Jones RS; Tu C; Zhang M; Qu J; Morris ME
Mol Pharmacol; 2019 Sep; 96(3):364-376. PubMed ID: 31436537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
